Harbour Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.1K	Buy	151 +35	+30%	+$11.9K	﹤0.01%	2339
2025 Q4	$46.1K	Sell	116 -11	-9%	-$4.87K	﹤0.01%	2004
2025 Q3	$57.9K	Buy	127 +31	+32%	+$12.6K	﹤0.01%	1834
2025 Q2	$31.3K	Buy	96 +5	+5%	+$1.38K	﹤0.01%	2027
2025 Q1	$24.6K	Sell	91 -42	-32%	-$10.8K	﹤0.01%	2096
2024 Q4	$31.3K	Buy	133 +2	+2%	+$526	﹤0.01%	1929
2024 Q3	$36K	Buy	131 +5	+4%	+$1.3K	﹤0.01%	1820
2024 Q2	$30.6K	Buy	126 +24	+24%	+$3.79K	﹤0.01%	1770
2024 Q1	$15.2K	Sell	102 -8	-7%	-$1.33K	﹤0.01%	2068
2023 Q4	$21.1K	Buy	110 +57	+108%	+$9.71K	﹤0.01%	1850
2023 Q3	$9.39K	Buy	53 +6	+13%	+$1.15K	﹤0.01%	2049
2023 Q2	$8.93K	Buy	47 +2	+4%	+$397	﹤0.01%	2085
2023 Q1	$9.01K	Buy	45 +4	+10%	+$841	﹤0.01%	2052
2022 Q4	$9.74K	Buy	+41	New	+$8.74K	﹤0.01%	1963